Derivados del indazol para el tratamiento del gammapatías monoclonales

Authors: Pérez-Simón, José A.; Barbado González, María Victoria; Medrano Domínguez, Mayte; Campillo, Nuria E.; Páez, Juan A.; González-Naranjo, Pedro;

handle: 10261/177525 , 10261/177524

Derivados del indazol para el tratamiento del gammapatías monoclonales

- Summary
- Metrics

Abstract

[EN] The invention relates to the use of a series of indazole compounds and the derivatives thereof in the production of a drug to be administered alone or combined with another suitable active ingredient in the treatment of cancer and, more specifically, the treatment of haematological cancer.

[ES] Uso de una serie de compuestos indazólicos y sus derivados en la elaboración de un medicamento para su administración, sólo o en combinación con otro principio activo adecuado en el tratamiento de las gammapatías monoclonales, y más concretamente en el mieloma múltiple (MM).

Servicio Andaluz de Salud, Consejo Superior de Investigaciones Científicas (España)

B1 Patente sin examen previo

Peer reviewed

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average